X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (8) 8
male (7) 7
pharmacology & pharmacy (7) 7
animals (5) 5
drugs (4) 4
enzymes (4) 4
medicine & public health (4) 4
pharmacology/toxicology (4) 4
research (4) 4
female (3) 3
genotype (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (3) 3
pharmacogenetics (3) 3
adult (2) 2
adverse drug-reactions (2) 2
aged (2) 2
analysis (2) 2
benzazepines - adverse effects (2) 2
cigarette-smoking (2) 2
cohort studies (2) 2
coronary-heart-disease (2) 2
cyclodextrins (2) 2
drug safety and pharmacovigilance (2) 2
drug-related side effects and adverse reactions - genetics (2) 2
enzym (2) 2
gene polymorphism (2) 2
genes (2) 2
genetic variation (2) 2
genome-wide association study (2) 2
genomes (2) 2
genomics (2) 2
guinea pig (2) 2
guinea pigs (2) 2
hippocampus (2) 2
hippocampus - drug effects (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (2) 2
internal medicine (2) 2
maze learning - drug effects (2) 2
memory (2) 2
middle aged (2) 2
morris water maze (2) 2
new zealand (2) 2
nicotinic agonists - adverse effects (2) 2
nigerians (2) 2
pharmacogenomic testing - methods (2) 2
pharmacokinetics (2) 2
pharmacology (2) 2
pharmacotherapy (2) 2
public, environmental & occupational health (2) 2
quinoxalines - adverse effects (2) 2
rat hippocampus (2) 2
rats, wistar (2) 2
side effects (2) 2
simvastatin (2) 2
smoking cessation - methods (2) 2
statin (2) 2
statins (2) 2
surveys and questionnaires (2) 2
toxicology (2) 2
varenicline (2) 2
2-hydroxypropyl-beta-cyclodextrin (1) 1
ace inhibitors (1) 1
ace protein (1) 1
ace-inhibitors (1) 1
adverse and side effects (1) 1
adverse drug reaction reporting systems (1) 1
adverse effects (1) 1
adverse events (1) 1
agarose gel electrophoresis (1) 1
allergy (1) 1
allotropy (1) 1
alzheimer-disease (1) 1
alzheimers-disease (1) 1
aminopeptidase-p (1) 1
amnesia - chemically induced (1) 1
amnesia - physiopathology (1) 1
angioedema (1) 1
angioneurotic edema (1) 1
angiotensin (1) 1
animals, newborn (1) 1
anions (1) 1
antipsychotic agents - adverse effects (1) 1
apolipoprotein-e genotypes (1) 1
arachidonic acids - pharmacology (1) 1
arachidonic acids - toxicity (1) 1
atorvastatin (1) 1
atorvastatin calcium (1) 1
atorvastatin, adverse reactions (1) 1
atria (1) 1
atrial function - drug effects (1) 1
b2 receptor (1) 1
behavior, animal - drug effects (1) 1
benzoxazines - pharmacology (1) 1
benzoxazines - toxicity (1) 1
beta-cyclodextrins - pharmacology (1) 1
beta-cyclodextrins - therapeutic use (1) 1
biomarkers - blood (1) 1
bleeding (1) 1
blood-pressure (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 4/2016, Volume 55, Issue 4, pp. 437 - 437
Journal Article
Pharmacogenomics, ISSN 1462-2416, 06/2011, Volume 12, Issue 6, pp. 773 - 774
Journal Article
New Zealand Medical Journal, ISSN 0028-8446, 12/2017, Volume 130, Issue 1466, pp. 62 - 69
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 10/2018, Volume 72, Issue 4, pp. 191 - 194
Journal Article
Pharmacogenomics, 06/2011, Volume 12, Issue 6, p. 773
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1620, pp. 65 - 74
Polymerase chain reaction (PCR) is an oft-used preparatory technique in amplifying specific DNA regions for downstream analysis. The size of an amplicon was... 
Proofreading enzyme | Thermal cycling | Agarose gel electrophoresis | Long amplicons | Long-range polymerase chain reaction (PCR) | Taq DNA polymerase | DNA - genetics | Nucleic Acid Amplification Techniques - methods | DNA Primers | Humans | Genome, Human - genetics | Polymerase Chain Reaction - methods | Index Medicus
Journal Article
Drug Safety, ISSN 0114-5916, 01/2012, Volume 35, Issue 1, p. 33
  Background: The smoking cessation medicine varenicline has been associated with an increased risk of cardiovascular adverse events compared with placebo in... 
Journal Article
Drug Metabolism and Personalized Therapy, ISSN 2363-8907, 03/2017, Volume 32, Issue 1, pp. 39 - 47
Journal Article
Drug metabolism and personalized therapy, 03/2017, Volume 32, Issue 1, p. 39
CYP1A2 and CYP2A6 are polymorphic drug-metabolising enzymes that are also implicated in the activation of procarcinogens in humans. Some of their alleles and... 
Cytochrome P-450 CYP2A6 - genetics | Humans | Cytochrome P-450 CYP2A6 - metabolism | Genotype | Male | Healthy Volunteers | Cytochrome P-450 CYP1A2 - metabolism | Cytochrome P-450 CYP2A6 - blood | Cytochrome P-450 CYP1A2 - blood | Phenotype | Cytochrome P-450 CYP1A2 - genetics | Female | Nigeria
Journal Article
Drug Safety, ISSN 0114-5916, 1/2011, Volume 34, Issue 1, pp. 1 - 19
The last decade has seen an increase in the trend of HMG-CoA reductase inhibitor (statin) usage in the Western world, which does not come as a surprise noting... 
Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Lovastatin, adverse reactions | Liver-disorders, drug-induced | Pitavastatin, adverse reactions | Pravastatin, adverse reactions | Pharmacogenetics | Simvastatin, adverse reactions | Rosuvastatin, adverse reactions | Cytochrome-P450 | HMG-CoA-reductase-inhibitors, general | HMG-CoA-reductase-inhibitors, adverse reactions | Fluvastatin, adverse reactions | Atorvastatin, adverse reactions | Muscular-disorders, drug-induced | Genetic-polymorphism | COA REDUCTASE INHIBITORS | GENETIC POLYMORPHISMS | GENDER-SPECIFIC MANNER | OATP-C SLC21A6 | P-GLYCOPROTEIN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | LIPID-LOWERING RESPONSE | PRIMARY HYPERCHOLESTEROLEMIA | APOLIPOPROTEIN-E GENOTYPES | PHARMACOLOGY & PHARMACY | LIPOPROTEIN CHOLESTEROL LEVELS | TOXICOLOGY | CORONARY-HEART-DISEASE | Cardiovascular Diseases - etiology | Genome-Wide Association Study | Cardiovascular Diseases - prevention & control | Humans | Cytochrome P-450 Enzyme System - metabolism | Polymorphism, Genetic | Genetic Variation | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Cardiovascular Diseases - mortality | Cytochrome P-450 Enzyme System - genetics | Cytochrome P-450 | Physiological aspects | Genetic aspects | Dosage and administration | Research | Genetic polymorphisms | Statins | Index Medicus | Drugs | Enzymes | Pharmacodynamics | Stroke | Cytochrome P450 | Liver | Mortality | Clinical trials | Esters | Cell membranes | CETP gene | Gene polymorphism | Statistics | Cholesterol | Proteins | Anions | statins | Hydroxymethylglutaryl-CoA reductase | Pharmacokinetics | prevention | Myopathy
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 02/2019, Volume 49, Issue 2, pp. 142 - 154
Journal Article